Evidence map›Paper›PMID 30535540›Full record

ArticleMagma (New York, N.Y.)2019

Quantitative CT and

Guan Wang, Yingli Fu, Steven M Shea, Shashank Sathyanarayana Hegde, Dara L Kraitchman

Abstract read
PubMed Publisher
In one paragraph

Article in Magma (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Multinuclear MRI in Drug Discovery.Molecules (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Guan WangRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, 600 N. Wolfe Street, 314 Park Building, Baltimore, MD, 21287, USA.
Yingli FuRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, 600 N. Wolfe Street, 314 Park Building, Baltimore, MD, 21287, USA.
Steven M SheaDepartment of Radiology, Stritch School of Medicine, Loyola University Chicago, Chicago, IL, USA.
Shashank Sathyanarayana HegdeRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, 600 N. Wolfe Street, 314 Park Building, Baltimore, MD, 21287, USA.
Dara L KraitchmanRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, 600 N. Wolfe Street, 314 Park Building, Baltimore, MD, 21287, USA. dkraitc1@jhmi.edu.
Johns Hopkins University · USLoyola University Chicago · US

Funding

X-ray & MR-visible Microencapsulation of Allogeneic Arteriogenic Cell TherapeuticR33HL089029 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KRAITCHMAN, DARA L · 2009 to 2011
$2.1M
Maryland Stem Cell Research Fund (US) 2008-MDSCRFII-0399National Heart, Lung, and Blood Institute R33-HL089029
6 · The paper itself

Abstract

objectivesPeripheral artery disease (PAD) affects 12-14% of the world population, and many are not eligible for conventional treatment. For these patients, microencapsulated stem cells (SCs) offer a novel means to transplant mismatched therapeutic SCs to prevent graft immunorejection. Using c-arm CT and MATERIALS AND

methodsXMRCaps were produced by impregnating 12% perfluorooctylbromine (PFOB) with rabbit or human SCs (AlloSC and XenoSC, respectively). Volume and

resultsXMRCap volumes and concentrations showed good agreement between CT and MRI both in vitro and in vivo in XenoSC rabbits. Injected capsules showed small variations over time and were similar between AlloSC and XenoSC rabbits. Histological staining revealed high cell viability and intact capsules 2 weeks after administration.

conclusionsQuantitative and non-invasive tracking XMRCaps using CT and

Indexed as

Fluorine-19 Magnetic Resonance ImagingTomography, X-Ray ComputedAlgorithmsAnimalsCalibrationCell LineageCell TransplantationDisease Models, AnimalDrug CompoundingFluorineFluorocarbonsGraft RejectionHumansHydrocarbons, BrominatedImage Processing, Computer-AssistedInjections, IntramuscularFluorineFluorocarbonsHydrocarbons, Brominatedperflubron19F-MRIEncapsulated stem cellsImmunorejectionPeripheral artery diseaseQuantitative tracking

Identifiers

PMID30535540
OpenAlexW2904764739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.